Committees

Brexit and the implications for UK business inquiry

Inquiry

This inquiry works on a sectoral basis. The Committee will start by looking at the civil nuclear sector, including membership of Euratom. It will then look at the Automotive, Aerospace, Processed food and drink and Pharmaceuticals sectors.

The Committee aims to establish how the interests of different sectors should best be pursued both in the negotiating process and post-Brexit and attempts to examine a range of issues relating to market access, non-tariff barriers, regulation, skills, R&D, trade opportunities and transitional arrangements.

Reports, special reports and government responses

View all reports and responses
16th Report - The response from business to the Withdrawal Agreement and Political Declaration
Inquiry Brexit and the implications for UK business inquiry
Open PDF
Opens in new window
Open HTML
Opens in new window
HC 384
Report

Correspondence

View all correspondence
Letter from the Rt Hon Greg Clark MP, Secretary of State for Business, Energy and lndustrial Strategy, relating the Government's preparations for EU exit, 30 March 2019
Inquiry Brexit and the implications for UK business inquiry
Open PDF
Opens in new window
Correspondence
Letter to the Rt Hon Greg Clark MP, Secretary of State for Business, Energy and Industrial Strategy, relating to the Government's progress in mitigating the impact of Brexit, 6 March 2019
Inquiry Brexit and the implications for UK business inquiry
Open PDF
Opens in new window
Correspondence
Letter from the Royal Aeronautical Society to the Chair, regarding value of lost space contracts due to Brexit, dated 4 December 2018
Inquiry Brexit and the implications for UK business inquiry
Open PDF
Opens in new window
Correspondence

Oral evidence transcripts

View all oral evidence transcripts
4 December 2018
Inquiry Brexit and the implications for UK business inquiry
Witnesses Tony Walker, Deputy Managing Director, Toyota Motor Europe, Sydney Nash, Senior Policy Manager, SMMT, Dermot Sterne, Chief Executive, Applied Component Technologies
Open PDF
218KB
Open HTML
182KB
Oral Evidence
28 November 2018
Inquiry Brexit and the implications for UK business inquiry
Witnesses Mike Thompson, Chief Executive, Association of the British Pharmaceutical Industry, Mark Hicken, Chair of the American Pharmaceutical Group and Managing Director, Janssen UK, Pinder Sahota, General Manager and Corporate VP, Novo Nordisk UK
Open PDF
169KB
Open HTML
221KB
Oral Evidence
28 November 2018
Inquiry Brexit and the implications for UK business inquiry
Witnesses Katherine Bennett, Senior Vice-President, Airbus UK, Simon Henley, President, Royal Aeronautical Society, Paul Everitt, Chief Executive, ADS Group
Open PDF
203KB
Open HTML
261KB
Oral Evidence

Written evidence

View all written evidence
Department for Business, Energy and Industrial Strategy (BRU0009)
Open PDF
81KB
Open HTML
34KB

Other publications

Other documents
Other documents connected to the committee's work.
1 published

Contact us

  • Email: commonsbtc@parliament.uk
  • Phone: 020 7219 8586 (General enquiries) | 020 7219 6970 (media enquiries)
  • Address: Business and Trade Committee, House of Commons, London, SW1A 0AA